Evaluating the Feasibility and Acceptability of an Artificial-Intelligence-Enabled and Speech-Based Distress Screening Mobile App for Adolescents and Young Adults Diagnosed with Cancer: A Study Protocol.
acceptability
adolescent and young adult cancer
artificial intelligence
distress
feasibility
vocal biomarkers
voice analysis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 Feb 2022
12 Feb 2022
Historique:
received:
11
12
2021
revised:
21
01
2022
accepted:
03
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Adolescents and young adults (AYAs) diagnosed with cancer are an age-defined population, with studies reporting up to 45% of the population experiencing psychological distress. Although it is essential to screen and monitor for psychological distress throughout AYAs' cancer journeys, many cancer centers fail to effectively implement distress screening protocols largely due to busy clinical workflow and survey fatigue. Recent advances in mobile technology and speech science have enabled flexible and engaging methods to monitor psychological distress. However, patient-centered research focusing on these methods' feasibility and acceptability remains lacking. Therefore, in this project, we aim to evaluate the feasibility and acceptability of an artificial intelligence (AI)-enabled and speech-based mobile application to monitor psychological distress among AYAs diagnosed with cancer. We use a single-arm prospective cohort design with a stratified sampling strategy. We aim to recruit 60 AYAs diagnosed with cancer and to monitor their psychological distress using an AI-enabled speech-based distress monitoring tool over a 6 month period. The primary feasibility endpoint of this study is defined by the number of participants completing four out of six monthly distress assessments, and the acceptability endpoint is defined both quantitatively using the acceptability of intervention measure and qualitatively using semi-structured interviews.
Identifiants
pubmed: 35205663
pii: cancers14040914
doi: 10.3390/cancers14040914
pmc: PMC8870320
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Transl Pediatr. 2013 Oct;2(4):167-97
pubmed: 26835313
Cancer Nurs. 2017 May/Jun;40(3):217-223
pubmed: 27271366
Psychooncology. 2019 Mar;28(3):577-585
pubmed: 30636177
J Adolesc Young Adult Oncol. 2016 Mar;5(1):48-57
pubmed: 26812452
Psychooncology. 2017 Sep;26(9):1307-1315
pubmed: 27862627
Crit Rev Oncol Hematol. 2021 Apr;160:103291
pubmed: 33675909
J Clin Oncol. 2020 Sep 20;38(27):3161-3174
pubmed: 32673152
Acta Oncol. 2015 May;54(5):789-96
pubmed: 25761086
Braz J Psychiatry. 2020 Nov-Dec;42(6):673-686
pubmed: 32321060
Pediatr Blood Cancer. 2019 Jun;66(6):e27668
pubmed: 30815985
Psychooncology. 2021 Nov;30(11):1849-1858
pubmed: 34160847
J Child Fam Stud. 2021;30(9):2303-2314
pubmed: 34230796
J Adolesc Young Adult Oncol. 2019 Dec;8(6):649-659
pubmed: 31329494
J Anxiety Disord. 2014 Aug;28(6):547-52
pubmed: 24983795
Psychooncology. 2019 Apr;28(4):675-686
pubmed: 30703261
Popul Health Metr. 2011 Apr 28;9:11
pubmed: 21527015
J Neurolinguistics. 2007 Jan;20(1):50-64
pubmed: 21253440
J Hematol Oncol. 2021 Jun 9;14(1):89
pubmed: 34108026
Psychooncology. 2018 Feb;27(2):532-538
pubmed: 28778113
J Adolesc Young Adult Oncol. 2019 Oct;8(5):560-565
pubmed: 31219363
Psychiatry Res. 2015 Oct 30;229(3):739-42
pubmed: 26275706
Pediatr Blood Cancer. 2016 Feb;63(2):337-43
pubmed: 26488337
J Voice. 2017 Mar;31(2):256.e1-256.e6
pubmed: 27473933
J Psychosoc Oncol. 2020 Sep-Oct;38(5):513-526
pubmed: 32449497
J Psychosoc Oncol. 2019 May-Jun;37(3):287-300
pubmed: 30938622
Syst Rev. 2014 Oct 27;3:124
pubmed: 25348422
J Natl Compr Canc Netw. 2017 Jul;15(7):903-912
pubmed: 28687578
Cancer. 2011 May 15;117(10 Suppl):2289-94
pubmed: 21523748
Cancer. 2005 May 1;103(9):1949-56
pubmed: 15770689
Psychooncology. 2020 Oct;29(10):1630-1637
pubmed: 32672854
J Natl Compr Canc Netw. 2013 Feb 1;11(2):214-21
pubmed: 23411387
Front Psychol. 2019 Aug 06;10:1713
pubmed: 31447721
Cancer. 2012 Dec 15;118(24):6260-9
pubmed: 22674666
J Clin Oncol. 2013 Jun 10;31(17):2160-6
pubmed: 23650425
J Psychosoc Oncol. 2018 Mar-Apr;36(2):137-144
pubmed: 28934026
Eur J Oncol Nurs. 2020 Feb;44:101708
pubmed: 31874354
J Pediatr Oncol Nurs. 2015 Sep-Oct;32(5):278-83
pubmed: 25556108
J Natl Cancer Inst. 2021 Aug 2;113(8):948-950
pubmed: 33839777
Cancer J. 2018 Nov/Dec;24(6):328-335
pubmed: 30480578
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Laryngoscope Investig Otolaryngol. 2020 Jan 31;5(1):96-116
pubmed: 32128436
CA Cancer J Clin. 2020 Nov;70(6):443-459
pubmed: 32940362
Psychooncology. 2018 Jul;27(7):1802-1809
pubmed: 29644783
J Psychopathol Behav Assess. 2017 Mar;39(1):140-146
pubmed: 28260835
Psychol Assess. 2018 Jun;30(6):719-728
pubmed: 29199838
Transl Psychiatry. 2016 Jul 19;6:e856
pubmed: 27434490